JP MORGAN/PUT/TEVA PHARMACEUTICAL INDUSTRIES/8/1/17.01.25 Share Price

Warrant

DE000JL622M3

Real-time Bid/Ask 01:56:02 17/06/2024 pm IST
0.046 EUR / 2.05 EUR +2,281.82% Intraday chart for JP MORGAN/PUT/TEVA PHARMACEUTICAL INDUSTRIES/8/1/17.01.25
Current month-24.14%
1 month-25.42%
Date Price Change
14/24/14 0.044 -4.35%
13/24/13 0.046 -2.13%
12/24/12 0.047 -14.55%
11/24/11 0.055 -3.51%
10/24/10 0.057 -3.39%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 03:21 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer J.P. Morgan
WKN JL622M
ISINDE000JL622M3
Date issued 11/07/2023
Strike 8 $
Maturity 17/01/2025 (215 Days)
Parity 1 : 1
Emission price 1.37
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.46
Lowest since issue 0.042
Delta-0.09x
Omega 1.437
Premium59.92x
Gearing15.29x
Moneyness 0.4662
Difference Strike -9.16 $
Difference Strike %-114.50%
Spread 2.003
Spread %97.71%
Theoretical value 1.049
Implied Volatility 122.76 %
Total Loss Probability 64.67 %
Intrinsic value 0.000000
Present value 1.049
Break even 6.877 €
Theta-0.04x
Vega0.02x
Rho-0.01x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
17.16 USD
Average target price
18.34 USD
Spread / Average Target
+6.85%
Consensus